This review provides and discusses current knowledge of the involvement of CCR2, CCR5, and their ligands in diabetic neuropathy and obesity-induced hypersensitivity (summarized in Table 1 and Table 2), emphasizing evidence from rodent-based studies. Here, CCR5 is linked to obesity disorder.